P042026
Non-billableNewborn affected by noxious substances transmitted via placenta or breast milk
Clinical Notes
- any current condition in newborn, if applicable
FAQ
Related Codes
P04Newborn affected by noxious substances transmitted via placenta or breast milk
P04.0Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
P04.1Newborn affected by other maternal medication
P04.11Newborn affected by maternal antineoplastic chemotherapy
P04.12Newborn affected by maternal cytotoxic drugs
P04.13Newborn affected by maternal use of anticonvulsants
P04.14Newborn affected by maternal use of opiates
P04.15Newborn affected by maternal use of antidepressants
P04.16Newborn affected by maternal use of amphetamines
P04.17Newborn affected by maternal use of sedative-hypnotics
P04.18Newborn affected by other maternal medication
P04.19Newborn affected by maternal use of unspecified medication
P04.1ANewborn affected by maternal use of anxiolytics
P04.2Newborn affected by maternal use of tobacco
P04.3Newborn affected by maternal use of alcohol
P04.4Newborn affected by maternal use of drugs of addiction
P04.40Newborn affected by maternal use of unspecified drugs of addiction
P04.41Newborn affected by maternal use of cocaine
P04.42Newborn affected by maternal use of hallucinogens
P04.49Newborn affected by maternal use of other drugs of addiction
P04.5Newborn affected by maternal use of nutritional chemical substances
P04.6Newborn affected by maternal exposure to environmental chemical substances
P04.8Newborn affected by other maternal noxious substances
P04.81Newborn affected by maternal use of cannabis
P04.89Newborn affected by other maternal noxious substances
P04.9Newborn affected by maternal noxious substance, unspecified